Description
• রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
Indications:
For improved glycemic control in adult patients with type 2 diabetes mellitus, used alongside diet and exercise.
Pharmacology:
Empagliflozin inhibits sodium-glucose co-transporter 2 (SGLT2) in kidneys, reducing glucose reabsorption and increasing its excretion via urine.
Dosage:
Typically 25 mg once daily, taken in the morning, with or without food.
Administration:
Oral administration; swallow the tablet whole with water.
Interaction:
Possible interactions with diuretics, insulin, and other antidiabetic drugs.
Contraindications:
Type 1 diabetes, severe renal impairment, hypersensitivity to Empagliflozin.
Side Effects:
Increased urination, urinary tract infections, genital infections, dehydration.
Pregnancy & Lactation:
Use only if clearly needed and after medical advice.
Precautions & Warnings:
Monitor renal function; ensure adequate hydration during treatment.
Therapeutic Class:
SGLT2 inhibitor, antidiabetic agent
Storage Conditions:
Store in a cool, dry place below 30°C, away from direct light.
Change Language